These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 15119308)
1. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). Antiretroviral therapy: the naïve patient. Gallant JE Hopkins HIV Rep; 2004 Mar; 16(2):1-4. PubMed ID: 15119308 [No Abstract] [Full Text] [Related]
2. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). The treatment of experienced patients and resistance mechanisms. Lucas GM Hopkins HIV Rep; 2004 Mar; 16(2):6-7, 15. PubMed ID: 15119309 [No Abstract] [Full Text] [Related]
3. Report from the 11th conference on retroviruses and opportunistic infections. Studies of approved antiretrovirals. Feinberg J AIDS Clin Care; 2004 Apr; 16(4):26-7. PubMed ID: 15124581 [No Abstract] [Full Text] [Related]
4. Treatment of experienced patients and antiretroviral resistance issues from the 12th CROI. Lucas GM Hopkins HIV Rep; 2005 Mar; 17(2):1-3, 12. PubMed ID: 16419315 [No Abstract] [Full Text] [Related]
5. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). The tenacity of NNRTI drug resistance. Persaud D; Gallant JE Hopkins HIV Rep; 2004 Mar; 16(2):1, 5, 15. PubMed ID: 15119307 [No Abstract] [Full Text] [Related]
9. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). Management of treatment-naïve patients. Gallant JE Hopkins HIV Rep; 2007 Mar; 19(2):1-3, 12. PubMed ID: 17882785 [No Abstract] [Full Text] [Related]
11. Report from the 12th Retrovirus Conference. Adherence. Friedland GH; Nagy GS AIDS Clin Care; 2005 Apr; 17(4):36. PubMed ID: 15875309 [No Abstract] [Full Text] [Related]
12. Antiretroviral rounds. Putting resistance to work. Daar ES; Elion R AIDS Clin Care; 2004 Jul; 16(7):56, 60. PubMed ID: 15300926 [No Abstract] [Full Text] [Related]
13. The year in review: antiretroviral treatment. Hirschel B; Opravil M AIDS; 1999; 13 Suppl A():S177-87. PubMed ID: 10885775 [No Abstract] [Full Text] [Related]
14. Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons. Spear GT; Olinger G; Sullivan BL; Landay AL; Kessler H; Connick E; Kuritzkes D; St Clair M; Spritzler J; Wu H; Lederman MM AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1713-5. PubMed ID: 10606095 [No Abstract] [Full Text] [Related]
15. Protease inhibitors: opium of the masses? Martinez LJ Res Initiat Treat Action; 2000 Sep; 6(3):7-11. PubMed ID: 11708167 [No Abstract] [Full Text] [Related]
16. [The 39th ICAAC (San Francisco) and the 7th European Conference on Clinical Aspects and Treatment of HIV-infection (Lisbon). HIV infection: antiretroviral agents in the development and trial stage]. Duval X Presse Med; 2000 Feb; 29(5):253-6. PubMed ID: 10701407 [No Abstract] [Full Text] [Related]
17. New versions of antiretroviral guidelines contain some important changes. Murphy MJ Fac Notes (New Orleans La); 1999; 11(4):1-3. PubMed ID: 11810843 [No Abstract] [Full Text] [Related]
18. Report from ICAAC: new drugs and antiretroviral therapy for naïve patients. Gallant JE Hopkins HIV Rep; 2002 Nov; 14(6):1-3, 7. PubMed ID: 12491989 [No Abstract] [Full Text] [Related]
19. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Introduction. TreatmentUpdate; 2003; 15(3):1. PubMed ID: 17216843 [No Abstract] [Full Text] [Related]